Nexosome Oncology
PrivateLast Round
Seed
Nov 1, 2021
Total Funding Raised
$4M
Company Overview
Nexosome Oncology is a biotechnology company that develops blood tests for early-stage cancer detection using extracellular vesicle proteomics and AI/ML biomarker discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nexosome Oncology Comparables
Compare Nexosome Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mursla Bio | 78% | |
| Mercy BioAnalytics | 77% | |
| Biological Dynamics, Inc. | 71% |
Nexosome Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 1, 2021 |
Nexosome Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DigiTx Partners | Seed |
| VisionTech Partners | Seed |
| Kentucky Science and Technology Corporation | Seed |
| Esplanade Ventures | Seed |
| XLerateHealth | Seed |
| OCA Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2021
$4M round with participation from DigiTx Partners and Esplanade Ventures.
Nexosome Oncology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nexosome Oncology's valuation, stock price, and market status.
Is Nexosome Oncology a public or private company?
Nexosome Oncology is a private company.
What is the current stock price of Nexosome Oncology?
Nexosome Oncology is a private company with no public stock price. No recent secondary market data is available.
How much is Nexosome Oncology worth (valuation)?
Valuation information for Nexosome Oncology is not publicly available.
Can I buy Nexosome Oncology stock?
Nexosome Oncology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nexosome Oncology's last funding round?
Nexosome Oncology's most recent funding round was Seed on November 1, 2021.
Who are the main investors in Nexosome Oncology?
Key investors in Nexosome Oncology include DigiTx Partners, VisionTech Partners, Kentucky Science and Technology Corporation, Esplanade Ventures, XLerateHealth.
Will Nexosome Oncology IPO soon?
No public IPO plans have been announced for Nexosome Oncology.
How can I track Nexosome Oncology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nexosome Oncology's secondary market activity and sign up for updates.